mothertobaby semaglutide pregnancy fact sheet 2025 tirzepatide breastfeeding Staying in Scope: Understanding COVID-19 and GLP-1 Medication Exposures in GLP-1s and Breastfeeding — Bridges – Semaglutide - MotherToBaby | Fact

Participants were randomized to semaglutide 2.4 mg weekly or placebo, followed for 72 weeks, and evaluated on both liver histology and metabolic endpoints

Weight loss progression timeline Expected results by timeframe: Individual variation: Starting weight affects absolute pounds (higher weight = more pounds lost) Same percentage loss = different pound amounts Example: 240 lb person loses 15-25% = 36-60 lbs 180-204 lbs final Example: 180 lb person loses 15-25% = 27-45 lbs 135-153 lbs final Responder categories from trials: Use SeekPeptides to track your CagriSema progress and optimize dosing based on your response

If you believe you are having an allergic reaction, seek medical attention immediately

Some early studies are exploring whether GLP-1 medications like Ozempic may help protect nerve cells in the retina

It is specifically designed to be gentle on your body and to ease you into this program with very minimal to no side effects